Decode Duchenne provides free genetic testing, interpretation, and counseling to people with Duchenne or Becker muscular dystrophy who meet certain eligibility criteria and who have been unable to access genetic testing in the past due to financial barriers, such as cost or lack of insurance coverage. Decode Duchenne is administered by DuchenneConnect, a program of Parent Project Muscular Dystrophy, and is supported by Sarepta Therapeutics, BioMarin Pharmaceuticals, and PTC Therapeutics.
- Have a confirmed or suspected diagnosis of Duchenne or Becker muscular dystrophy
- Are citizens or legal residents of the United States or Canada
- Have financial barriers to receiving genetic testing
A genetic counselor from DuchenneConnect will help interested patients and families find out if they are eligible to participate.
Decode Duchenne automatically provides deletion/duplication testing with reflex to sequencing of the DMD gene for participants who have never had testing. The program can also provide sequencing only for those who have already had negative deletion/duplication testing and familial mutation testing. Additionally, repeat testing is available for individuals tested with older technologies that did not analyze all exons in the DMD gene. The Decode Duchenne genetic counselors can help determine which tests are needed.
Contact Decode Duchenne to learn more